Azafaros
Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Azafaros use?+
Azafaros uses 11 technologies including Flickity, Google Analytics, Google Tag Manager.
What industry is Azafaros in?+
Azafaros operates in the Biotechnology industry.
Where is Azafaros based?+
Azafaros is headquartered in Thailand.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026